MaxCyte, Inc.
MXCT
$2.61
$0.062.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 38.63M | 45.60M | 45.44M | 44.05M | 41.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.63M | 45.60M | 45.44M | 44.05M | 41.29M |
| Cost of Revenue | 7.10M | 6.39M | 5.26M | 5.15M | 4.74M |
| Gross Profit | 31.53M | 39.21M | 40.18M | 38.91M | 36.55M |
| SG&A Expenses | 56.36M | 57.96M | 57.87M | 57.72M | 57.04M |
| Depreciation & Amortization | 4.14M | 4.19M | 4.20M | 4.14M | 3.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.83M | 91.99M | 91.73M | 91.45M | 89.59M |
| Operating Income | -51.20M | -46.39M | -46.29M | -47.40M | -48.30M |
| Income Before Tax | -41.06M | -35.74M | -35.43M | -36.57M | -37.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.06 | -35.74 | -35.43 | -36.57 | -37.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.06M | -35.74M | -35.43M | -36.57M | -37.92M |
| EBIT | -51.20M | -46.39M | -46.29M | -47.40M | -48.30M |
| EBITDA | -46.88M | -42.03M | -41.92M | -43.08M | -44.13M |
| EPS Basic | -0.39 | -0.34 | -0.34 | -0.35 | -0.37 |
| Normalized Basic EPS | -0.24 | -0.21 | -0.21 | -0.22 | -0.23 |
| EPS Diluted | -0.39 | -0.34 | -0.34 | -0.35 | -0.37 |
| Normalized Diluted EPS | -0.24 | -0.21 | -0.21 | -0.22 | -0.23 |
| Average Basic Shares Outstanding | 419.39M | 417.54M | 415.88M | 414.31M | 413.06M |
| Average Diluted Shares Outstanding | 419.39M | 417.54M | 415.88M | 414.31M | 413.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |